Efficacy of Ayush medicine NOQ19 in treatment of Covid-19 patients
Not Applicable
Completed
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2021/05/033790
- Lead Sponsor
- Sriveda Sattva Private Limited Sri Sri Tattva
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 150
Inclusion Criteria
Symptomatic COVID 19 infection with or without comorbidities
Willingness to participate in the study
Indian nationals
Exclusion Criteria
Age less than 18 years or more than 75 years
Pregnancy and Lactation
Patient not willing to participate in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the effect of NOQ19 in COVID 19 patients in time to become SARS COV2 RT-PCR negative, reducing the symptoms and duration of hospital stayTimepoint: 7 days for each participant
- Secondary Outcome Measures
Name Time Method Effect of NOQ19 therapy on laboratory parameters - CBC, RBS, KFT, LFT, CRPTimepoint: Entry and Exit